Boston, MA, United States of America

Ramesh Ganju

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ramesh Ganju. Retrieved from https://idiyas.com/inventor/ramesh-ganju-3r91uu5g

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ramesh Ganju: Innovator in T Cell Receptor Technology

Introduction

Ramesh Ganju is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of immunology, particularly in the development of soluble single chain T cell receptors. His work has implications for therapeutic applications in various diseases.

Latest Patents

Ramesh Ganju holds a patent for "Soluble single chain T cell receptors." This patent encompasses soluble, single chain T cell receptors, nucleic acid sequences, particularly DNA sequences, encoding the soluble, single chain T cell receptor, expression vectors containing the DNA sequences, and host cells containing the expression vectors. He has 1 patent to his name.

Career Highlights

Throughout his career, Ramesh has focused on advancing the understanding of T cell biology. His innovative approaches have paved the way for new therapeutic strategies in treating immune-related conditions.

Collaborations

Ramesh has collaborated with esteemed colleagues such as Ellis L Reinherz and Stephen T Smiley. These partnerships have enhanced the research and development of his patented technologies.

Conclusion

Ramesh Ganju's contributions to the field of immunology through his innovative patents highlight his role as a key inventor in advancing T cell receptor technology. His work continues to influence the landscape of therapeutic development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…